An FDA-cleared and CE-marked software for automated labeling, visualization, and volumetric quantification of brain structures and lesions from MRI scans to support CNS disease diagnosis and monitoring.

A research-use-only AI platform designed to predict CNS disease progression by integrating genomics, biofluids, neuroimaging, cognitive, and daily living data to guide health decisions and clinical trial patient selection.